Receiving a heart transplant is a life-changing journey, and you may be wondering about your treatment options. This is why The Heart Hub is excited to introduce A Hearts Journey: A Patient & Caregiver Guide to Heart Transplant. This brand-new, interactive...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Experts in our Cardiac Genome Clinic have developed a bioinformatics tool that you can use to assess whole genome and whole exome sequencing data, and better identify genetic variants that are causing disease.
“GeneTerpret” is a flexible platform designed to streamline the genome interpretation process, through a unique interface, with improved ease, speed and accuracy. Upload data, filter it using integrated databases, and receive a priority list of the highest-potential disease-causing genes or variants in that particular patient.
GeneTerpret greatly reduces the time and labour often required to comb through databases, clinical histories and available literature in order to analyze a sample. GeneTerpret has the potential to save hours on each case, freeing analysts to spend more time hunting for new disease-related genes.
An open access study describing this tool and its achievements is published in February 2022.